» Articles » PMID: 36171082

Postinfective Bowel Dysfunction Following is Characterised by Reduced Microbiota Diversity and Impaired Microbiota Recovery

Overview
Journal Gut
Specialty Gastroenterology
Date 2022 Sep 28
PMID 36171082
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Persistent bowel dysfunction following gastroenteritis (postinfectious (PI)-BD) is well recognised, but the associated changes in microbiota remain unclear. Our aim was to define these changes after gastroenteritis caused by a single organism, , examining the dynamic changes in the microbiota and the impact of antibiotics.

Design: A single-centre cohort study of 155 patients infected with . Features of the initial illness as well as current bowel symptoms and the intestinal microbiota composition were recorded soon after infection (visit 1, <40 days) as well as 40-60 days and >80 days later (visits 2 and 3). Microbiota were assessed using 16S rRNA sequencing.

Results: PI-BD was found in 22 of the 99 patients who completed the trial. The cases reported significantly looser stools, with more somatic and gastrointestinal symptoms. Microbiota were assessed in 22 cases who had significantly lower diversity and altered microbiota composition compared with the 44 age-matched and sex-matched controls. Moreover 60 days after infection, cases showed a significantly lower abundance of 23 taxa including phylum Firmicutes, particularly in the order Clostridiales and the family increased Proteobacteria abundance and increased levels of Fusobacteria and Gammaproteobacteria. The microbiota changes were linked with diet; higher fibre consumption being associated with lower levels of Gammaproteobacteria.

Conclusion: The microbiota of PI-BD patients appeared more disturbed by the initial infection compared with the microbiota of those who recovered. The prebiotic effect of high fibre diets may inhibit some of the disturbances seen in PI-BD.

Trial Registration Number: NCT02040922.

Citing Articles

Melatonin alleviates heat stress-induced spermatogenesis dysfunction in male dairy goats by regulating arachidonic acid metabolism mediated by remodeling the gut microbiota.

Guo X, Xu J, Zhao Y, Wang J, Fu T, Richard M Microbiome. 2024; 12(1):233.

PMID: 39533343 PMC: 11559159. DOI: 10.1186/s40168-024-01942-6.


Mechanistic Insights on Microbiota-Mediated Development and Progression of Esophageal Cancer.

Moe K, Tan K Cancers (Basel). 2024; 16(19).

PMID: 39409925 PMC: 11475040. DOI: 10.3390/cancers16193305.


Gut promotes protective immunity to foodborne infection.

Wang X, Meng F, Zhang M, Li F, Lei Y, Ma Z Microbiol Spectr. 2024; 12(10):e0402523.

PMID: 39190634 PMC: 11448249. DOI: 10.1128/spectrum.04025-23.


Campylobacter jejuni virulence factors: update on emerging issues and trends.

Tikhomirova A, McNabb E, Petterlin L, Bellamy G, Lin K, Santoso C J Biomed Sci. 2024; 31(1):45.

PMID: 38693534 PMC: 11064354. DOI: 10.1186/s12929-024-01033-6.


Exploring causality in the association between gut microbiota and irritable bowel syndrome risk: a large Mendelian randomization study.

Zhang J, Shi X, Wang Y Aging (Albany NY). 2024; 16(8):7448-7459.

PMID: 38669090 PMC: 11087118. DOI: 10.18632/aging.205771.


References
1.
McNulty C, Lasseter G, Newby K, Joshi P, Yoxall H, Kumaran K . Stool submission by general practitioners in SW England - when, why and how? A qualitative study. BMC Fam Pract. 2012; 13:77. PMC: 3481435. DOI: 10.1186/1471-2296-13-77. View

2.
Spiller R, Humes D, Campbell E, Hastings M, Neal K, Dukes G . The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther. 2010; 32(6):811-20. DOI: 10.1111/j.1365-2036.2010.04402.x. View

3.
Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J . The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007; 133(1):24-33. DOI: 10.1053/j.gastro.2007.04.005. View

4.
Liu H, Zhang H, Wang X, Yu X, Hu C, Zhang X . The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes. Surg Obes Relat Dis. 2018; 14(5):584-593. DOI: 10.1016/j.soard.2018.01.012. View

5.
Spiller R, Jenkins D, Thornley J, Hebden J, Wright T, Skinner M . Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000; 47(6):804-11. PMC: 1728147. DOI: 10.1136/gut.47.6.804. View